Core Viewpoint - Jiangsu Wango Pharmaceutical is transforming its business model by integrating sports sponsorship with its pharmaceutical operations, aiming to enhance brand visibility and promote health awareness through its new family health IP "Wang Family" [1][2][3] Group 1: Business Transformation - The company adopted a "dual-driven" strategy focusing on both generic and innovative drug development, allocating 10%-16% of annual sales to R&D, and establishing R&D centers in Nanjing and Tianjin with a team of over 260 [2][3] - The latest approved product, Amlodipine and Olmesartan Medoxomil Tablets, achieved a quarterly production of 5 million tablets, with 17 new generic drugs launched last year, ranking tenth in national drug approval numbers [2] - The first innovative drug is entering Phase III clinical trials, with expectations for market launch in 2026, supported by a 2 billion yuan biopharmaceutical project established in March last year [2][5] Group 2: Sports Sponsorship and Brand Strategy - The sponsorship of the Nantong team in the Jiangsu City Football League aligns with the company's vision to connect health with sports, creating a cultural and emotional bond with the community [3][4] - The "Wang Family" health IP features characters that resonate with local culture, promoting various health aspects such as male health, family health, and children's health [2][3] - The sponsorship has significantly increased the visibility of the Nantong team, leading to a surge in ticket demand, with over 1.1 million people attempting to purchase tickets for a match [3][4] Group 3: Product Development and Market Strategy - The company is leveraging the excitement of the football matches to promote its products, such as calcium supplements and joint health solutions, through various marketing channels during the events [4] - The goal is to communicate the message of "hundreds of commonly used drugs, carefully crafted by Wango" while building a product matrix that addresses male health, maternal care, and children's protection [4] - The initiative includes a "National Health Plan" that engages the audience through interactive activities, enhancing customer loyalty and brand recognition [4][5]
从实验室到绿茵场:姚俊华与江苏万高药业的“三栖”破局之路
Zhong Guo Chan Ye Jing Ji Xin Xi Wang·2025-06-27 11:20